RECRUITING

Development of an mHealth Behavioral Sleep Medicine Intervention for Use During Medication Assisted Treatment for MOUD

Description

This study is to develop and test a medical health application based on cognitive behavioral therapy for insomnia and augmented with other evidence-based sleep interventions that address common sleep-related problems in opioid use disorder. An initial program will be built utilizing input from persons beginning medications for opioid use disorders.

Study Overview

Study Details

Study overview

This study is to develop and test a medical health application based on cognitive behavioral therapy for insomnia and augmented with other evidence-based sleep interventions that address common sleep-related problems in opioid use disorder. An initial program will be built utilizing input from persons beginning medications for opioid use disorders.

Development of an mHealth Behavioral Sleep Medicine Intervention for Use During Medication Assisted Treatment for Opioid Use Disorder

Development of an mHealth Behavioral Sleep Medicine Intervention for Use During Medication Assisted Treatment for MOUD

Condition
Opioid Use Disorder
Intervention / Treatment

-

Contacts and Locations

Charleston

Medical University of South Carolina, Charleston, South Carolina, United States, 29464

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * No experience of withdrawal symptoms in past 2 weeks
  • * Being stabilized on buprenorphine
  • 1. Initiated buprenorphine in past 3 months
  • 2. Modified buprenorphine dose in past 3 months (e.g., reducing dose with goal of transitioning to vivitrol)
  • * Currently experiencing clinically significant sleep disturbance (PSQI \> 5)
  • * Able to read and understand English
  • * Owns an Android or iOS smartphone
  • * At least 18 years of age
  • * Current psychotic symptoms
  • * Current active suicidal ideation
  • * Severe visual impairment
  • * Current use of benzodiazepines
  • * Current severe SUD other than OUD (i.e., \> 5 criteria met for any other SUD type per DSM-5)
  • * Peripartum women

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Medical University of South Carolina,

Allison K Wilkerson, Ph.D., PRINCIPAL_INVESTIGATOR, Medical University of South Carolina

Study Record Dates

2026-05-01